 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price(s) |
Delete |
Y3197325 |
 |
(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethan-1-aminedihydrochloride |
95%
|
$470/50mg, $685/100mg, $975/250mg, $1535/500mg, $1965/1g |
 |
Y3264564 |
 |
2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethanamine |
95%
|
$170/50mg, $200/100mg, $265/250mg, $410/500mg, $510/1g |
 |
Y4000198 |
 |
2-(azidomethyl)naphthalene |
95%
|
|
 |
K05200 |
 |
2-fluoro-4-(oxiran-2-yl)benzonitrile |
>95%
|
$750/1g, $2850/5g |
 |
Y3157838 |
 |
2-methyl-6-[2-(trimethylsilyl)ethynyl]quinoline |
95%
|
$275/50mg, $405/100mg, $565/250mg, $885/500mg, $1135/1g, $2215/2.5g, $3280/5g |
 |
Y3201337 |
 |
3-(difluoromethyl)-2-methylaniline hydrochloride |
95%
|
$340/50mg, $495/100mg, $690/250mg, $1085/500mg, $1390/1g |
 |
Y1411680 |
 |
3-Chloro-6,7-dihydro-5H-cyclopenta[b]pyridine 1-Oxide |
95%
|
$1650/1g |
 |
Y1335983 |
 |
4,4'-DIHYDROXY-2,2'-BIPYRIDINE |
97%
|
$85/100mg, $110/250mg, $190/1g, $475/5g |
 |
Y3103874 |
 |
4-chloro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenol |
95%
|
$190/50mg, $260/100mg, $365/250mg, $665/500mg, $860/1g, $1675/2.5g, $2475/5g |
 |
Y3176302 |
 |
4-chloro-6-cyclopropyl-2-methylpyrimidine |
95%
|
$340/50mg, $500/100mg, $700/250mg, $1100/500mg, $1410/1g, $2760/2.5g, $4080/5g |
 |
Y1291262 |
 |
5-Bromofuran-2-carbohydrazide |
98%
|
$60/1g, $100/5g |
 |
Y3153656 |
 |
5-ETHOXY-2-THIEN-2-YL-1,3-OXAZOLE-4-CARBOXYLIC ACID |
98%
|
$165/50mg, $185/100mg, $255/250mg, $380/500mg, $480/1g |
 |
Y3182666 |
 |
lithium(1+) ion 2-[2-({[(tert-butoxy)carbonyl]amino}methyl)pyridin-4-yl]acetate |
95%
|
$365/50mg, $530/100mg, $760/250mg, $1190/500mg, $1530/1g, $2985/2.5g, $4415/5g |
 |
Y3295950 |
 |
Morpholine, 4-(2,6-dichloro-4-pyridinyl)- |
95%+
|
|
 |
Y3255270 |
 |
N-benzyl-2-hydroxypropanamide |
95%
|
$160/50mg, $180/100mg, $245/250mg, $430/500mg, $580/1g |
 |
Y3292480 |
 |
RK-701 |
98%
|
$440/1mg, $870/5mg, $1355/10mg, $2620/25mg |
 |
Y1344188 |
 |
tert-Butyl N-[(2S)-1-carbamoylpropan-2-yl]carbamate |
98%
|
$130/100mg, $190/250mg, $385/1g, $1315/5g |
 |
|
|
|
 |
 |
 |